INTRODUCTION
Deposition of amyloid-b peptide (Ab) as b-amyloid plaques is a hallmark pathology of Alzheimer's disease (AD). Traditionally, Ab has been characterized as a functionless catabolic byproduct and pathways leading to b-amyloid generation as intrinsically pathological. However, mounting data suggest this long-standing model for Ab pathogenesis requires revision. Recent findings have identified Ab as an antimicrobial peptide (AMP) and suggest Ab deposition may be a protective innate immune response to infection (Bourgade et al., 2015 (Bourgade et al., , 2016 Kumar et al., 2016; Soscia et al., 2010; White et al., 2014) . A physiological role for Ab as an AMP is also consistent with the peptide's remarkably high sequence conservation across multiple phyla-the human Ab sequence is at least 400 million years old and is found in 60%-70% of vertebrate species (Luna et al., 2013) . We have proposed that in AD, normally protective antimicrobial pathways mediated by Ab oligomerization are overactivated, either by real or incorrectly perceived infection. Ongoing Ab deposition drives neuroinflammation, leading to neuropathology and widespread neuronal death. We call this model the antimicrobial protection hypothesis of AD (R. D.M. et al., unpublished data) .
AMPs are evolutionarily conserved proteins that mediate a diverse range of protective functions in innate immunity, including antibiotic-like microbial killing and immuno-modulating activities. Oligomerization is integral to normal AMP function, and soluble oligomers are the bioactive species in a range of innate immune pathways (Arnusch et al., 2007; Chu et al., 2012; Hoover et al., 2000; Oren et al., 1999; Xhindoli et al., 2014) . Amyloid fibril generation is also important for AMP activities, mediating disruption of microbial cell membranes (Sood et al., 2008) , neutralization of bacterial endotoxins (Wang et al., 2014) , and pathogen agglutination and entrapment (Chu et al., 2012; Torrent et al., 2012) . However, dysregulated AMP oligomerization can also lead to serious pathologies, including inflammation, tissue degeneration (Paulsen et al., 2002; Pereira et al., 1996; Reinholz et al., 2012; Scarpa et al., 2012) , and deposition as amyloid in at least three human amyloidopathies (Araki-Sasaki et al., 2005; Ciornei et al., 2006; Kee et al., 2008; Linke et al., 2005; Millucci et al., 2011; Pá lffy et al., 2009; Reinholz et al., 2012; Scarpa et al., 2012; Yamaguchi et al., 2007; Zhao et al., 2008) . Thus, AMP oligomerization carries a potential for protective/damaging duality in human health.
Alois Alzheimer first proposed infection may play a role in AD (Fischer, 1907) . However, until recently there has been limited support for an infection-based AD etiology (Itzhaki et al., 2016) . Renewed interest in possible roles for infection has been driven, in part, by recent reports of elevated levels of pathogen-derived epitopes in AD brain (Alonso et al., 2014; Harris and Harris, 2015; Pisa et al., 2015) and emerging experimental, genetic, and epidemiological data suggesting innate immune-mediated inflammation propagates neurodegeneration (Griciuc et al., 2013; Heneka et al., 2015; Perez-Nievas et al., 2013) . Herpes simplex virus 1 (HSV1) is the human pathogen most frequently linked to AD amyloidosis (Harris and Harris, 2015; Itzhaki, 2014; Itzhaki et al., 1997; Mawanda and Wallace, 2013) . Herpesviridae proteins are reported to interact with the products of many AD susceptibility genes (Carter, 2008) . HSV1 upregulates Ab generation (Wozniak et al., 2007) and herpesviridae DNA signals co-localize with amyloid plaques in AD brain (Wozniak et al., 2009 ). Here, we investigated the activities of Ab against the neurotropic herpesviridae viruses HSV1 and herpesvirus 6A (HHV6A) and 6B (HHV6B). Herpesviridae are ubiquitous human pathogens with neuroinfection in the general population approaching 100% (Campadelli-Fiume et al., 1999; Jamieson et al., 1991) . HSV1 undergoes acute and episodic reactivation between long periods of dormancy. The continuous low-level replication of HHV6A and HHV6B is implicated in an increasing spectrum of chronic inflammatory diseases with foci both inside and outside the CNS (Hill and Venna, 2014) . In this same issue, an increased abundance of Roseoloviruses HHV6 and HHV7, and HSV1 has also been reported in the brains of AD patients (Readhead et al., 2018) .
In this study, we report that Ab oligomers inhibit HSV1 infection in vitro and significantly protect 5XFAD transgenic mice from acute viral encephalitis. Furthermore, we demonstrate that Ab binds and agglutinates HSV1 and HHV6 viruses, and identify herpesviridae envelope glycoproteins as binding targets. Our data are consistent with rapid and dramatic viral seeding of b-amyloid in the brain, in which various conformers of Ab serve as innate intra-CNS mediators of resistance that protects the brain against herpesviridae infection.
RESULTS
Ab-mediated antiviral activity was tested in mouse encephalitis and cell culture infection models. For the encephalitis model, transgenic AD mice (5XFAD) and wild-type (WT) littermates were compared for survival following stereotactic injection of 5 3 10 6 PFU/mL HSV1 into the hippocampal region of each brain hemisphere. Mice are poor experimental models for investigating HHV6 infections (Lusso, 1996) . The human cell receptors for HHV6A (CD46) and HHV6B (CD134) have low sequence homology with murine homologs. Thus, HHV6 infectivity was investigated in cell culture, including human neuroglioma (H4) monolayer models and the recently reported 3D human stem cell-derived neural cell culture system that recapitulates both b-amyloid plaque and neurofibrillary tangles (Choi et al., 2014) . Oligomer-depleted synthetic Ab were prepared as previously described . Cellderived oligomeric Ab species were harvested from conditioned media generated by H4 cells stably transformed with a BRI-Ab42 fusion protein (H4-Ab42) or a Chinese hamster ovary cell line overexpressing the amyloid b-protein precursor (APP) and b-secretase (CHO-CAB) . CHO-CAB cells express both 40 (Ab40) and 42 (Ab42) residue Ab isoforms while H4-Ab42 cells predominately express Ab42. Conditioned H4-Ab42 and CHO-CAB media predominately contain polydisperse polymorphic soluble oligomer species assembled from between 2 and 20 Ab monomer units . Synthetic Ab peptides used in experiments were prepared under conditions that minimize soluble oligomer generation.
Ab Protects against HSV1 Encephalitis in 5XFAD Transgenic Mice
To interrogate the protective antiherpetic activity of elevated Ab expression, we first employed a mouse HSV1 encephalitis mouse model. Five-to six-week-old 5XFAD transgenic mice constitutively express human Ab in the brain at high levels, but exhibit neither the b-amyloid deposits nor features of neuroinflammation observed in older (>4-month-old) animals (Oakley et al., 2006) . 5XFAD mice (n = 14) and WT (n = 9) littermates were administered HSV1 by intracerebral injection and followed for survival. Infected 5XFAD mice expressing Ab showed significantly (p = 0.045) increased survival compared to WT non-transgenic littermates ( Figure 1A ). Consistent with increased HSV1 resistance, weight loss was also significantly less (p = 0.013) for 5XFAD mice compared to WT littermates at 24 hr post-infection ( Figure 1B) . Sham viral injections did not result in 5XFAD or WT mouse mortality. Data are consistent with protective antiherpetic activity mediated by human Ab expression in transgenic 5XFAD mice.
WT ( Female transgenic mice (5XFAD), 5-6 weeks old, expressing human Ab were compared against wild-type (WT) littermates for survival following bilateral intracranial injections of HSV1. Following injection of viable HSV1, WT and 5XFAD mice were followed for (A) survival and (B) weight loss. No mortality was observed among sham-infected control. Statistical significance was calculated by log-rank (Mantel-Cox) test for survival and statistical means compared by t test for weight loss. Survival analysis data were pooled from five independent experiments.
Ab Inhibits HSV1 Infection of Host Cells in Culture
The protective activities of Ab against HSV1 were further characterized in an H4-N monolayer infection model using red fluorescent protein (RFP)-labeled virus. Compared to naive control samples (H4-N and CHO-N), host cell-associated HSV1-RFP signal was significantly attenuated with co-incubation in transformed H4-Ab42 and CHO-CAB conditioned media ( Figure 2 ). Consistent with Ab-specific antiviral activity, anti-Ab immunodepleted (ID) H4-Ab42 and CHO-CAB media did not inhibit HSV1. HSV1 was also not inhibited by pre-incubation of host cell with Ab or addition of peptide following infection ( Figure S1A ). Protection was concentration dependent, and consistent with our previous findings for fungal and bacterial pathogens, cell-derived Ab oligomers inhibit HSV1 at low nanomolar concentrations while synthetic peptide-treated disaggregate assemblies require micromolar concentrations ( Figure S1B ).
Ab Carbohydrate Binding Mediates Targeting of Herpesviruses
Next, we investigated the pathway mediating targeting of herpesviruses by Ab. Previously, we showed Ab inhibits bacterial and fungal pathogens by binding directly to microbial surface carbohydrates . Ab binding of microbial cells is mediated by the peptide's heparin-binding domain. Ab oligomers, but not monomeric peptide, show heparin-binding activity Watson et al., 1997) . Thus, soluble oligomers appear to be the Ab species targeting and binding microbes. Carbohydrate binding promotes Ab fibrilization and leads to protofibril generation on microbial surfaces. Bound protofibrils first inhibit host cell adhesion by pathogens. Then, propagating Ab fibrils mediate agglutination and sequestration of microbes within fibrillar b-amyloid.
The heparin-binding domain of Ab has previously been shown to target microbial surface carbohydrates in in vitro binding assays . We assayed Ab binding to HSV1 and HHV6 A and B viral particles using a modified Ab-binding ELISA. Synthetic or cell-derived Ab was incubated with heat-immobilized virus in microtiter plate wells. b-amyloid generated on viral surfaces was then detected immunochemically with anti-Ab antibodies. Consistent with Ab targeting of herpes viruses, binding signal was observed following incubation of synthetic Ab42 and H4-Ab42 and CHO-CAB conditioned media with immobilized HSV1, HHV6A, and HHV6B virus ( Figures 3A and 2 ). Cell-derived Ab oligomers bound herpes viruses at peptide levels reported for normal brain (0.5-2 ng/mL). Consistent with specificity for Ab binding, signal was attenuated for anti-Ab immunodepleted culture samples and scrambled Ab42 peptide. Competitive inhibition of pathogen binding by soluble microbial sugars is a hallmark for AMPs with activities mediated by lectin-like carbohydrate binding (Tsai et al., 2011b) . Consistent with carbohydrate-mediated virus binding, the yeast polysaccharide mannan inhibited Ab binding to immobilized HSV1 ( Figure 3A ). Next, we investigated possible carbohydrate moieties on herpesviridae that Ab may target. Classical heparin-binding AMPs target viral glycoproteins, including LL-37 (Pachó n-Ibá ñ ez et al., 2017) and q and a-defensins (Hazrati et al., 2006) . Immobilized HSV1 was pre-incubated with antibodies to herpesviridae glycoproteins B (gB), C (gC), D (gD), E (gE), H (gH), or G (gG) prior to incubation with conditioned CHO-CAB media. Compared to untreated wells, signal was attenuated following pre-incubation with anti-glycoprotein antibodies ( Figure 3B ). Collectively, data are consistent with antiherpetic activities mediated by Ab-binding herpesviridae glycoproteins.
Soluble microbial sugars inhibited binding signal for CHO-CAB and H4-Ab42 conditioned media by 56% and 73%, respectively ( Figure 3A) . However, higher mannan concentrations or other microbial sugars did not further reduce binding under our experimental conditions (data not shown). This suggests Ab binding of viral glycoproteins may not be the sole pathway mediating targeting of herpesviridae. Consistent with alternative/complementary herpes targeting pathways, Bourgade et al. (2016) report HSV1 inhibition mediated by binding of a proximal region of gB with high sequence homology to Ab (Bourgade et al., 2016) .
Oligomerization of Viral-Bound Ab Inhibits Infectivity of Herpesviruses Anti-adhesion and agglutination activities against microbial cells are mediated by Ab fibrilization following binding of oligomeric species to surface carbohydrates . We next investigated whether Ab fibrilization also mediates the peptide's ability to inhibit HSV1 and HHV6. Consistent with a fibrilizationmediated inhibition model, transmission electron micrographs (TEMs) of HSV1, HHV6A, or HHV6B incubated with H4-Ab42 media revealed fibrillar structures attached to viral envelopes ( Figure 4A ). Fibril generation on viral surfaces was rapid, occurring in <15 min. Virus particles were linked by a fibrillar network following 60 min incubation and sequestered within insoluble agglutinates within 2 hr. Identity of the entrapping fibrillar structures as Ab42 fibrils was confirmed by anti-Ab (mAb 4G8) labeling using immunogold nanoparticles ( Figure S3A ). Incubation of viruses with anti-Ab immunodepleted control media did not generate fibril networks or lead to agglutination. Data from our 3D neural cell culture system were also consistent with findings from monolayer cell culture models. Under sterile conditions, observable Ab deposits are normally not generated in the 3D cell neural culture system until the sixth week of culture (Choi et al., 2014) . However, extensive Ab-positive deposits were observed in 3-week-old cultures within 48 hr of infection with HSV1, HHV6A, or HHV6B ( Figures 4B and 4C ). Following staining with Thioflavin S, matrigel Ab/HSV1 deposits displayed the enhanced fluorescence that marks the presence of amyloid fibrils ( Figures S3B and S3C) . Moreover, viral signal co-localized with Ab deposits generated in cell culture, consistent with viral agglutination and entrapment mediated by fibrilization. In contrast, Ab aggregates were not observed in control cell cultures infected with UV-inactivated virus ( Figure S3D ).
The data from the cell culture experiments are consistent with antiherpetic Ab activities mediated by b-amyloid generation. Consistent with this model, protective Ab entrapment of infecting bacteria induced rapid seeding of b-amyloid in 5XFAD brain . Thus, we next tested whether HSV1 infection also seeds Ab deposition in young 5XFAD mice. Young 5XFAD mice do not develop Ab deposits until 10-12 weeks of age. The brains of 5-to 6-week-old 5XFAD mice and WT littermates given intracranial HSV1 injections were analyzed for Ab deposition. Anti-amyloid staining revealed b-amyloid deposition within the subiculum of young 5XFAD mice within 48 hr following infection ( Figure 4D ). Consistent with HSV1-mediated Ab seeding, HSV1 immunofluorescence and Ab signals co-localized. Infected control WT littermates and sham-injected 5XFAD did not show Ab disposition. Notably, non-lethal HSV1 dosing led to advanced b-amyloid/HSV1 deposition in layer V of the cortex of 5XFAD mice 3 weeks following infection ( Figure 4E ). b-amyloid deposits initially generated with acute HSV1 infection appear amorphous. However, 3 weeks post-infection, b-amyloid deposits can be observed with immunostaining morphologies that resemble mature senile plaques found in AD brain ( Figure 4E ).
Our data from cell culture and mouse models are consistent with Ab-mediated protection from HSV1 and HHV6, involving a classical AMP mechanism of viral entrapment, here, by Ab fibrils and deposits. These findings indicate that antimicrobial activities of Ab fibrils and deposits may be important for defending brain against common viral infections. In addition, our findings that viral, as well as bacterial and fungal, infections rapidly and dramatically seed b-amyloid suggest a broad spectrum of pathogens carry the potential to mediate b-amyloidosis in AD patients.
DISCUSSION
HSV1 is the pathogen most strongly linked to AD with over 100 publications directly or indirectly supporting an association with the disease (with only three that conflict, all published over 12 years ago) (Itzhaki et al., 2016) . Most recently, a 16-year-long study involving over 33,000 patients found HSV1 infection increases AD risk 2.5-fold (Tzeng et al., 2018) . Moreover, long-term administration of anti-herpetic medications appears to reduce AD risk for HSV1-infected patients. Our data reveal a mechanism by which the presence of extracellular herpesviridae viruses may directly seed Ab deposition and accelerate AD pathogenesis. Recent findings using 3D human stem cell-derived neural cultures have shown that Ab generation is sufficient to induce neurofibrillary tangles (Choi et al., 2014) . Current data suggest severe neurodegeneration may require the presence of all three major AD pathologies (i.e., plaques, NFTs, and neuroinflammation) (Perez-Nievas et al., 2013). Our current findings are not in and of themselves evidence that herpes infections generate b-amyloidosis in AD brain. However, our findings reveal a plausible mechanism for the genesis of b-amyloidosis driven by the low-grade but persistent viral presence that characterizes chronic symptomatic or subclinical herpesviridae CNS infections. Data showing increased resistance to HSV1 (Figure 1 ) and accelerated Ab deposition with infection ( Figures  4D and 4E ) in 5XFAD mice are consistent with findings from our cell culture experimental models, in which Ab antimicrobial activities were mediated by fibrilization. However, for herpesviridae infections in humans, the immediate protection afforded by Ab entrapment may carry a long-term risk for AD-related pathogenic b-amyloidosis. Possible factors mediating a shift in AD brain from protective to neuropathological Ab deposition include pathogen virulence and persistence, host genetics, and environmental factors. Importantly, in the antimicrobial protection model, neurodegeneration is not mediated by pathogen activities that directly kill neurons. Rather, Ab innate immune pathways targeting pathogens mediate the AD neuropathogenesis that leads to widespread neurodegeneration. Thus, our model is consistent with the amyloid cascade hypothesis and overwhelming data showing the primacy of Ab in AD pathology.
Binding of host brain glycosaminoglycans (GAGs) induces Ab fibrilization and is most often characterized as an exclusively pathological event associated with b-amyloidosis (van Horssen et al., 2003) . However, carbohydrate binding and fibrilization are considered normally protective activities among AMPs, playing key roles in microbial targeting and agglutination (Chu et al., 2012; Torrent et al., 2012; Tsai et al., 2011a Tsai et al., , 2011b Yount et al., 2006) . Data are consistent with Ab's carbohydrate-binding activity mediating targeting and binding of viral surface glycoproteins (Figure 3) . Binding of HSV1 and HHV6 induces rapid Ab fibrilization in cell culture models ( Figure 4A ). Bound Ab oligomers and propagating protofibrils on viral surfaces likely sterically inhibit host cell adhesion and herpes glycoprotein activities mediating HSV1 and HHV6 entry (Figure 2 ). TEM data reveal rapid glycoprotein-induced Ab fibrilization leads to a network of captured viral particles linked by fibrils within 30 min. Finally, in both cell culture and AD mouse models, Ab fibrilization leads to the sequestering and neutralization of HSV1 and HHV6 viruses in insoluble fibril/virus agglutinates ( Figures 4B-4E) . b-amyloid generated in 3D culture and 5XFAD mouse models during acute HSV1 infection appear amorphous. However, 3 weeks post-infection, deposits in 5XFAD brain show immunohistological morphologies strikingly similar to mature senile plaques in AD brain ( Figure 4E ). Findings suggest non-lethal HSV1 infection could be useful for accelerating the onset of plaque generation in young 5XFAD and possibly additional transgenic AD mouse models.
In our cell culture experimental models, herpes glycoproteininduced fibrils are generated 1-2 orders of magnitude more rapidly than reported for Ab fibrilization mediated by GAGs (Castillo et al., 1998) . Since viruses minimize extracellular exposure, rapid Ab fibrilization is likely advantageous for inhibiting and capturing HSV1 and HHV6 before they adhere to host cells. These new data for Ab-mediated viral agglutination are consistent with findings for bacterial and fungal aggregation and suggest that microbial sugars, rather than host GAGs, may be the normal in vivo target for the heparin-binding activity of Ab oligomers.
Ab is an ancient, highly conserved, and widely expressed vertebrate protein. Phylogenetic analyses indicate the herpesviridae family is 300-400 million years old with herpes pathogens identified across all seven classes of vertebrate (McGeoch and Gatherer, 2005) . Thus, Ab and herpes viruses likely have a long history as adversaries. The longevity and remarkable widespread conservation of the human Ab42 sequence across vertebrates suggest the peptide's antiherpetic activities are both efficacious and difficult for herpes viruses to counter. The antimicrobial activities of Ab are not limited to herpesviridae. Prior in vitro studies have shown that Ab can also inhibit seasonal and pandemic strains of influenza A virus (White et al., 2014 ) and a range of bacterial and fungal pathogens (Soscia et al., 2010) . Collectively, these findings suggest Ab oligomerization mediates highly successful innate immune pathways that are intrinsically resistant to evolution of microbial countermeasures. This stands in stark contrast to prevailing views of Ab oligomerization that characterize self-association and aggregation of the peptide as strictly abnormal and exclusively pathological events. A fuller elucidation of the key role that oligomerization plays in the normal activities of Ab is likely to help advance our understanding of the etiology and pathogenesis of AD and better inform current and future AD therapeutic strategies aimed at preventing pathological Ab accumulation.
Finally, with regard to a possible herpes infection-based etiology for AD, the risk for amyloidosis and HSV1 infection in brain both increase with age. The decline of adaptive immunity and blood-brain barrier integrity with advancing senescence is thought to enable HSV1 to travel from the peripheral nervous system to the CNS and be acquired as a new brain infection via the olfactory route. Declining immunity in old age is thought to also allow increased HHV6 replication in brain. However, data supporting a role for herpesviridae, or other infections, are widely held as equivocal. Nonetheless, our identification of a plausible pathway for direct viral mediation of b-amyloid deposition and recent transcriptomic data confirming increased abundance of herpes viruses in AD brain (Readhead et al., 2018) add to mounting evidence that viral and other microbial infections may, indeed, play an important role in the etiology and pathogenesis of this devastating neurodegenerative disease.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: Ren-VM (male), VERO (female), H4-Naive or Ab42 (male), and CHO-Naive or CAB (female) cells were all housed in 37 C incubators with 5% CO 2 and R 93% humidity. H4-Ab42 and CHO-CAB were maintained by selection antibiotics and all cell lines were authenticated by morphology checks at both cell seeding and confluency growth stages.
METHOD DETAILS AD mouse infection model
Female 5XFAD APP/PS1 transgenic mice (Oakley et al., 2006 ) that overexpress Ab42 from inheritable FAD mutant forms of human APP (the Swedish mutation: K670N, M671L; the Florida mutation: I716V; the London mutation: V717I) and PS1 (M146L; L286V) transgenes under transcriptional control of the neuron-specific mouse Thy-1 promoter (Tg6799 line). 5XFAD lines (B6/SJL genetic background) were purchased from Jackson Laboratory and maintained by crossing heterozygous transgenic mice with B6/SJL F1 breeders. All 5XFAD transgenic mice were heterozygotes with respect to the transgene.
Five-to-six-week old mice received bilateral injections (2 ml) of HSV1 viron (5 3 10 6 PFU/ml) suspension at AP, À2.0; medium containing Dulbecco's modified Eagle's medium (DMEM), 10% fetal bovine serum (FBS), 2 mM L-glutamine, 100 U penicillin, and streptomycin (100 mg/ml) until confluence. For infection experiments, media was replaced with 24 hr conditioned media from H4-N, H4-Ab42, or CHO-CAB cells containing HSV1 (3 3 10 5 PFU). Synthetic Ab42 was incubated with HSV1 and host cells in H4-N conditioned media. As a negative control and serial dilution diluent, H4-Ab42 conditioned media was immunodepleted with anti-Ab antibodies. Following 2 hours incubation with virus, media was aspirated and cultures washed X3. Fresh media was applied and infected host cells incubated for 20-22 hours. Cells were trypsinized, washed, then fixed in 4% paraformaldehyde for 20 minutes. Cells were then re-suspended in PBS and analyzed for RFP signal on LSRII flow cytometer (BD Biosciences, San Jose, CA)
3D neuronal cell culture system Procedures for preparation of 3D human stem cell-derived neural cell cultures have been described previously (Choi et al., 2014) . Briefly, ReNcell VM human neural precursor cells (Billerica, MA, USA) were added to BD Matrigel (BD Biosciences, San Jose, CA) containing ReN cell differentiation medium and transferred to the wells of 96-well culture plates (100 ml per well containing 2 x10 5 cells). The 3D-plated cells were differentiated for 3 weeks prior to experimentation.
For pathogen exposure, 100 mL of media was removed and replace with equal volume media containing either HSV1 or HHV6 (3 x10 4 PFU). Cells were exposed to viral pathogens for 48 to 72 hr and then washed and fixed overnight in 4% paraformaldehyde for analysis.
Ab-binding ELISA
The wells of 96-well plates were incubated (80 C) with live virus (3x10 5 PFU/well) in deionized water (50 ml/well) until wells were dry
(1-2 hr). Wells were then washed X5 with Tris buffered saline (TBS) containing 0.05% Triton X-100 (TBST) to remove unattached virus and then blocked with 5% BSA in TBS for 2 hr at RT. Samples for testing were incubated (1 hr at 37 C) in virus-coated wells (100 mL /well) and following washing with TBST, bound Ab detected immunochemically by incubation (overnight at 4 C) with a-Ab42-HRP (Covance, Princeton, NJ) and development with chemiluminescence reagent (Pierce, Rockford IL). For glycoprotein binding experiments, virus-coated wells were pre-incubated (4 C overnight) with antibodies (1 mg/ml) against glycoproteins B (a-gB), C (a-gC), D (a-gD), E (a-gE), G (a-gG), or H (a-gH)
Tissue preparation and sectioning For immunofluorescence, mice were deeply anesthetized with isoflurane, and perfused transcardially with 4% paraformaldehyde in cold PBS when possible. Brains were post-fixed overnight and then transferred into a 30% sucrose solution until sedimented. Sagittal sections (30 mm) were cut from an ice-cooled block using a sliding microtome (Leica, Wetzlar, Germany). Sections were stored at À20 C in cryoprotective buffer containing 28% ethylene glycol, 23% glycol and 0.05 M phosphate until processing for analysis.
Immunofluorescence labeling
Immunofluorescence labeling was performed as described previously (Oakley et al., 2006) . Briefly, sections or wells were probed with anti-Ab42 monoclonal rabbit (Thermo Fisher Scientific, Boston, MA) followed by anti-rabbit Dylight 405 secondary (Jackson ImmunoResearch, antibodies. For b-amyloid detection, free-floating sections or wells were incubated (8 min) with 0.002% Thioflavin S in TBS, rinsed twice for 1 min in 50% ethanol, washed for 5 min in TBS, and mounted with Prolong Gold antifade reagent (Life Technologies) or the wells were maintained in TBS. Stained sections were analyzed by fluorescence confocal microscopy on a Nikon C2s laser scanning microscope (Nikon, Tokyo, Japan).
Viral agglutination and TEM analysis HSV1 or HHV6 incubated in conditioned culture media for 15, 30, or 60 minutes at RT. Viral aggregates were pelleted, resuspended in PBS (5 ml), and absorbed to Formvar carbon coated copper grids (FCF100-Cu, Electron Microscopy Sciences, Hatfield, PA). Grids were blocked with 1% BSA in PBS (kept covered for 10 min at RT) then incubated (30 min at RT) with mAb 4G8 (1:1000) in blocking buffer. Grids were washed with PBS and incubated with goat anti-mouse-IgG antibody covalently linked to nanogold particles. Following three 5 min PBS washes and four 10 min water washes, specimens were fixed with 1% glutaraldehyde (10 min at RT). Specimens were washed with water, stained with uranyl acetate, and then viewed using a JEM-1011 Transmission Electron Microscope (JEOL Institute, Peabody, MA).
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analyses were performed with Prism software (version 7.0) using two tailed t tests to compare arithmetic means. Survival curves were compared using Log-rank (Mantel-Cox) test and confirmed by Gehan-Breslow-Wilcoxon test. P values < 0.05 were considered statistically significant.
